- Report
- September 2025
- 150 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- August 2025
- 150 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- August 2025
- 150 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- July 2025
- 150 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- June 2025
- 150 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- April 2025
- 150 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- March 2025
- 150 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- March 2025
- 150 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- March 2025
- 150 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- March 2025
- 150 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- March 2025
- 150 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- December 2024
- 150 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- September 2024
- 150 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Training
- July 2027
- 3 Hours
Global
€434EUR$486USD£350GBP
€496EUR$555USD£400GBP
- Training
- January 2027
- 3 Hours
Global
€434EUR$486USD£350GBP
€496EUR$555USD£400GBP
- Report
- October 2025
- 89 Pages
Global
From €4162EUR$4,500USD£3,473GBP
- Report
- October 2025
- 80 Pages
Global
From €4162EUR$4,500USD£3,473GBP
- Report
- October 2025
- 90 Pages
Global
From €4162EUR$4,500USD£3,473GBP
- Report
- October 2025
- 82 Pages
Vietnam
From €4162EUR$4,500USD£3,473GBP
- Report
- October 2025
- 85 Pages
Middle East
From €4162EUR$4,500USD£3,473GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more